Journal profile · Medicine-Oncology
Acta Haematologica Polonica
ISSN 0001-5814 · eISSN 2300-7117 · Walter de Gruyter
Acta Haematologica Polonica: impact factor 0.6 (journal website); diamond open access (no APC); no APC; 89 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Acta Haematologica Polonica is published by Walter de Gruyter. By OpenAlex counts of its recent articles, its largest topics are Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Immunodeficiency and Autoimmune Disorders, together about 29.8% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
“Acta Haematologica Polonica” (AHP) is a peer-reviewed, English language, gold open-access journal. It is the official bimonthly of the Polish Society of Haematologists and Transfusiologists as well as the Institute of Haematology and Transfusion Medicine. The Journal has been associated with haematology and transfusion since 1970. AHP publishes original research articles, clinical vignettes, and reviews. "Acta Haematologica Polonica" covers areas of physiology and pathology in hematology and transfusion medicine, among other leucocytes, erythrocytes, platelets, immune system, mechanisms of hemostasis and clinical aspects of haematological malignancies. Journal publishes: original studies, reviews, expert guidelines, short communications, clinical vignettes, letters to the Editor, and editorials.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Oncology
Editor-in-chief Bartosz PułaPublisher website
Editorial board by country: none in mainland China; most named Poland 35, United States 4, Germany 3, United Kingdom 2, Sweden 2 (50 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chronic Lymphocytic Leukemia ResearchMedicine14.5%
- Lymphoma Diagnosis and TreatmentMedicine8.5%
- Immunodeficiency and Autoimmune DisordersImmunology and Microbiology6.9%
- Chronic Myeloid Leukemia TreatmentsMedicine6.3%
- Acute Lymphoblastic Leukemia researchMedicine5.6%
- Multiple Myeloma Research and TreatmentsMedicine5.4%
- Acute Myeloid Leukemia ResearchMedicine4.9%
- Myeloproliferative Neoplasms: Diagnosis and TreatmentMedicine4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Google Scholar, EBSCO, CNKI, J-Gate, OCLC, Crossref, Arianta, Biosis Previews (WoS), CNKI (China National Knowledge Index), Index Copernicus, Polish Medical Library (GBL), SJR (Scimago Journal & Country Rank), WorldCat (OCLC)Publisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 0.6Publisher website ·
- CiteScore 2026-06
- 1.2LetPub ·
- CiteScore (publisher)
- 1.2Publisher website ·
- SJR 2026-06
- 0.16LetPub ·
- SNIP 2026-06
- 0.24LetPub ·
- h-index
- 14OpenAlex ·
- i10-index
- 27OpenAlex ·
- 2-year mean citedness
- 0.39OpenAlex ·
- Self-citation rate
- 33.3%LetPub ·
- Share of gold OA articles
- 95.77%LetPub ·
Volume
- Articles per year
- 47LetPub ·
Articles by year OpenAlex count · 1,390 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 54 | 54 | 2 |
| 2025 | 89 | 89 | 31 |
| 2024 | 58 | 58 | 45 |
| 2023 | 76 | 76 | 84 |
| 2022 | 63 | 63 | 129 |
| 2021 | 97 | 97 | 280 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Submission to publication (journal-reported)
- about 14 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-ND |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Reference style
- Vancouver
- Suggested reviewers
- Required, 2
- Cover letter
- Required
Article types accepted7, with length limits
- case reportAccepted papers are published in the following journal sections: Original research article, Review article, Editorial, Expert guidelines, Short communication, L…main text ≤ 2,000 words
- editorialAccepted papers are published in the following journal sections: Original research article, Review article, Editorial, Expert guidelines, Short communication, L…Length not stated
- letter to the editorAccepted papers are published in the following journal sections: Original research article, Review article, Editorial, Expert guidelines, Short communication, L…Length not stated
- original research articleAccepted papers are published in the following journal sections: Original research article, Review article, Editorial, Expert guidelines, Short communication, L…Length not stated
- reviewfield and identify future implications. Reviews should not exceed 5000 words, 10 figures or tables, and 100 references. They should contmain text ≤ 5,000 words
- review articleAccepted papers are published in the following journal sections: Original research article, Review article, Editorial, Expert guidelines, Short communication, L…Length not stated
- short communicationAccepted papers are published in the following journal sections: Original research article, Review article, Editorial, Expert guidelines, Short communication, L…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Self-archiving
- Authorship Changes to authorship
Detailed author contributions required; CRediT recommended. Model summary
Authors are expected to carefully consider the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, …
Source ↗Publisher website ·- Conflicts of interest Declaration of conflict of interest
Conflict of interest disclosure required. Model summary
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/ registrations, and grants or other funding. Authors must disclose any interests in two plac…
Source ↗Publisher website ·- Data availability
Data availability statement required. Model summary
Authors should indicate whether the source data underlying the submitted manuscript are available to other researchers.
Source ↗Publisher website ·- Publication ethics
Adherence to COPE principles. Model summary
Publisher and Editors of the Journal strongly recommends that journal editors, authors and readers adhere to the principles of the Committee on Publication Ethics (COPE), particularly in dealing with ethical misconduct.
Source ↗Publisher website ·- License & copyright Copyright Notice
Completion of the online submission form electronically (the Author's Statement) is tantamount to automatic transfer of the copyright for publishing and distribution of the submitted material (in all current and future forms and fields of exploitation) to the Copyright Owner, i.e., Polish Society Haematology and Blood Transfusion, Institute of Haematology and Transfusion Medicine, on condition tha…
Source ↗Publisher website ·- Open access Open Access Policy
All articles published in “Acta Haematologica Polonica” are available in open access formula and are published under Creative Common Attribution-Non Commercial-No Derivatives 4.0, International Licence (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commerci…
Source ↗Publisher website ·- Peer review REVIEW PROCESS
Manuscripts are evaluated on the basis that they present new insights into the investigated topic and are likely to contribute to a research progress or change in clinical practice or in thinking about a disease. It is understood that all authors listed on a manuscript have agreed to its submission. The signature of the corresponding author on the letter of submission signifies that these conditio…
Source ↗Publisher website ·- Plagiarism Preventing Plagiarism
To exclude even unintentional plagiarism, “Acta Haematologica Polonica” (AHP) has introduced Ithenticate software, widely known in the academic community. All papers accepted for publication are now automatically screened within the manuscript system. Additionally, Editors may decide to run a similarity report at any other point during the review process or post-publication. Our Editorial team is …
Source ↗Publisher website ·- Self-archiving Self-archiving Policy
Via Medica (Publisher) self-archiving policy establishes that authors can archive only accepted manuscripts, including the final PDF version and/or ‘ahead of print’ in any repository. In details, the author may only post their version provided acknowledgment is given to the original source of publication, and a link is inserted to the published article on Via Medica (Publisher) website. Apart from…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Walter de Gruyter
- ISSN
- 0001-5814
- Electronic ISSN
- 2300-7117
- Society / sponsor
- Polish Society of Haematologists and Transfusiologists and the Insitute of Haematology and Transfusion Medicine
- Latest issue on the website
- Volume 57, Issue 4 (2026)
- Official links
FAQ
Frequently asked questions about Acta Haematologica Polonica
What is the impact factor of Acta Haematologica Polonica?
The journal's website gives an impact factor of 0.6; this is the journal's own figure, as LetPub lists none for it; CiteScore 1.2, h-index 14.
What are the manuscript requirements of Acta Haematologica Polonica?
According to the journal's author guidelines: Reference style: Vancouver; Suggested reviewers: Required, 2; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Acta Haematologica Polonica based?
Of the 50 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Poland (35), United States (4) and Germany (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Acta Haematologica Polonica?
According to LetPub and DOAJ records, Acta Haematologica Polonica is indexed in ESCI, Scopus and DOAJ.
Is Acta Haematologica Polonica open access, and what is the APC?
Acta Haematologica Polonica is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .